InvestorsHub Logo
Followers 271
Posts 15407
Boards Moderated 1
Alias Born 03/28/2013

Re: XenaLives post# 179149

Tuesday, 01/22/2019 1:01:15 PM

Tuesday, January 22, 2019 1:01:15 PM

Post# of 458804
My gut feeling is they are monitoring CB1, CB2 receptors etc
Found extensively in the gut. Some of these receptors seem to migrate to the brain when "problems" arise

Watch @ 5:50

https://www.youtube.com/watch?v=n3fkiwTABag

Another informative study
https://content.iospress.com/articles/journal-of-alzheimers-disease/jad140492

https://www.anavex.com/anavex-encouraged-by-scientific-data-confirming-sigma-1-receptors-beneficial-direct-interaction-with-cannabinoid-receptor/

“With Anavex drug candidates targeting the sigma-1 receptor, and with the mechanism of action being further validated, we are even more encouraged to advance our studies with additional neurodegenerative diseases,” said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex. “The Company is intrigued to realize the direct link to the body’s endocannabinoid system and to proceed with potential studies with our sigma-1 drugs candidates and cannabinoids.”

~A MUST WATCH DOCUMENTARY~


https://www.youtube.com/watch?v=csbJnBKqwIw

Good luck everyone $AVXL
Patience And
Perspective big smile
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News